Search

Author/Creator Poynton, Matt

1. Efficacy of Isatuximab With Pomalidomide and Dexamethasone in Relapsed Myeloma: Results of a UK-Wide Real-World Dataset. Issue 6 (26th June 2022)

Authors:
Djebbari, Faouzi; Rampotas, Alexandros; Vallance, Grant; Panitsas, Fotios; Basker, Nanda; Sangha, Gina; Salhan, Beena; Karim, Farheen; Al-Kaisi, Firas; Gudger, Amy; Ngu, Loretta; Poynton, Matt; Lam, Ho Pui Jeff; Morgan, Lowri; Yang, Laura; Young, Jennifer; Walker, Mairi; Tsagkaraki, Ismini; Ander...
Journal:
HemaSphere
Issue:
Volume 6:Issue 6(2022)
Page Start:
e738
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Frailty subgroup analysis of isatuximab with pomalidomide and dexamethasone in a UK‐wide real‐world cohort of relapsed myeloma patients. (31st January 2023)

Authors:
Djebbari, Faouzi; Rampotas, Alexandros; Vallance, Grant; Panitsas, Fotios; Basker, Nanda; Sangha, Gina; Salhan, Beena; Karim, Farheen; Al‐Kaisi, Firas; Gudger, Amy; Ngu, Loretta; Poynton, Matt; Lam, Ho Pui Jeff; Morgan, Lowri; Yang, Laura; Young, Jennifer; Walker, Mairi; Tsagkaraki, Ismini; Ander...
Journal:
British journal of haematology
Issue:
Volume 201:Number 1(2023)
Page Start:
162
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Infections in relapsed myeloma patients treated with isatuximab plus pomalidomide and dexamethasone during the COVID-19 pandemic: Initial results of a UK-wide real-world study. Issue 1 (31st December 2022)

Authors:
Djebbari, Faouzi; Rampotas, Alexandros; Vallance, Grant; Panitsas, Fotios; Basker, Nanda; Sangha, Gina; Salhan, Beena; Karim, Farheen; Firas, Al-Kaisi; Gudger, Amy; Ngu, Loretta; Poynton, Matt; Lam, Ho Pui Jeff; Morgan, Lowri; Yang, Laura; Young, Jennifer; Walker, Mairi; Tsagkaraki, Ismini; Ander...
Journal:
Hematology
Issue:
Volume 27:Issue 1(2022)
Page Start:
691
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Outcomes of anti-CD38 isatuximab plus pomalidomide and dexamethasone in five relapsed myeloma patients with prior exposure to anti-C38 daratumumab: case series. Issue 1 (31st December 2022)

Authors:
Djebbari, Faouzi; Poynton, Matt; Sangha, Gina; Anderson, Laura; Maddams, Rebecca; Eyre, Toby A.; Vallance, Grant; Basu, Supratik; Ramasamy, Karthik
Journal:
Hematology
Issue:
Volume 27:Issue 1(2022)
Page Start:
204
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗